NCT04612413: A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients |
|
|
| Active, not recruiting | 2 | 160 | Europe, RoW | Allocetra-OTS, Placebo | Enlivex Therapeutics Ltd., Cato Research, Accelsiors CRO & Consultancy Services | Sepsis, Community-acquired Pneumonia, Urinary Tract Infections, Cholecystitis, Acute, Cholangitis Acute, Intraabdominal Infections | 12/24 | 03/25 | | |
